Related Experiment Video

Updated: Jun 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells

Alexander A Tinnikov1, Kay T Yeung, Sharmistha Das

  • 1Department of Pharmacology and Medicine, The Entertainment Industry Foundation Research Laboratory, New York University School of Medicine, New York, New York 10016, USA.

Cancer Research
|February 5, 2009
PubMed

Insights

Nuclear receptor interacting factor 3 (NRIF3) induces breast cancer cell death via caspase-2. A novel factor, DIF-1, regulates this process, suggesting a potential therapeutic target for selective breast cancer apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Pathways

Background:

  • Nuclear receptor interacting factor 3 (NRIF3) is a coregulator involved in various cellular processes.
  • Breast cancer cells exhibit specific sensitivities to certain apoptotic stimuli.
  • Understanding cell-type-specific death pathways is crucial for targeted cancer therapies.

Purpose of the Study:

  • To investigate the mechanism by which NRIF3 induces apoptosis in breast cancer cells.
  • To identify factors that modulate NRIF3-mediated apoptosis.
  • To explore the potential of targeting this pathway for selective breast cancer treatment.

Main Methods:

  • Expression of NRIF3 and its death domain (DD1) in breast cancer cells.
  • Yeast two-hybrid screening to identify NRIF3-interacting proteins.
  • Cloning and characterization of DD1-interacting factor-1 (DIF-1).
  • siRNA knockdown of DIF-1 and NRIF3.
  • Treatment with protein kinase A inhibitor (H89).

Main Results:

  • NRIF3 expression selectively triggers caspase-2-dependent apoptosis in breast cancer cells.
  • A novel death domain (DD1) in NRIF3 mediates this cytotoxicity.
  • DIF-1, a transcriptional repressor, was identified as a mediator of DD1-induced apoptosis.
  • DIF-1 binding to NRIF3/DD1 attenuates repression, and DIF-1 expression rescues cells from apoptosis.
  • siRNA knockdown of DIF-1 selectively induces breast cancer cell apoptosis.
  • H89 induces apoptosis in breast cancer cells, which is blocked by DIF-1.
  • H89 increases NRIF3 levels, and NRIF3 knockdown protects against H89-induced apoptosis.

Conclusions:

  • DIF-1 plays a critical role in breast cancer cell survival.
  • NRIF3/DD1-mediated apoptosis represents a novel, cell-specific death pathway.
  • Targeting the NRIF3/DIF-1 pathway offers potential for selective breast cancer therapies.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Mammosphere Assay Reveals Api5-Induced Stemness in Non-Tumorigenic Breast Epithelial Cell Lines08:05

Mammosphere Assay Reveals Api5-Induced Stemness in Non-Tumorigenic Breast Epithelial Cell Lines

Published on: February 24, 2026

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...